Gil Roth08.04.11
Mark Dmytruk has been named president of inVentiv Health Patient Outcomes. He is based at inVentiv’s headquarters in Burlington, MA.
Mr. Dmytruk has extensive experience in the healthcare, life sciences and diagnostics industries, including emerging and international market development. He joins inVentiv from Athena Diagnostics, where he was vice president of finance and part of the executive management team. Prior to Athena, he led corporate development at Thermo Fisher Scientific, where he managed M&A activity worldwide.
inVentiv Health Patient Outcomes offers support in patient adherence, patient reimbursement and assistance, disease management and cost containment, and risk management consulting. inVentiv companies operating under the inVentiv Health Patient Outcomes brand include Adheris, AWAC, inVentiv Patient Access Solutions and ParagonRx.
Mr. Dmytruk has extensive experience in the healthcare, life sciences and diagnostics industries, including emerging and international market development. He joins inVentiv from Athena Diagnostics, where he was vice president of finance and part of the executive management team. Prior to Athena, he led corporate development at Thermo Fisher Scientific, where he managed M&A activity worldwide.
inVentiv Health Patient Outcomes offers support in patient adherence, patient reimbursement and assistance, disease management and cost containment, and risk management consulting. inVentiv companies operating under the inVentiv Health Patient Outcomes brand include Adheris, AWAC, inVentiv Patient Access Solutions and ParagonRx.